{
    "Case ID": "051130",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "lack of utility",
                "obviousness"
            ],
            "infringement_analysis": [
                "ACE inhibitors",
                "antihypertensive agents",
                "proline moiety",
                "enalapril backbone"
            ],
            "expert_testimony": [
                "involved in trial"
            ],
            "relevant_rule": [
                "utility through factual evidence or sound prediction",
                "not obvious to a person skilled in the art"
            ],
            "decision_reasoning": [
                "unreliable prediction of utility",
                "substitution considered obvious based on prior art"
            ],
            "result_of_case": [
                "invalidation of claims 1, 2, 3, 6, and 12",
                "defendants' counterclaim allowed"
            ],
            "procedure_steps": [
                "trial involving expert testimonies",
                "analysis of prior art",
                "experimental data",
                "legal principles regarding utility, obviousness, and double patenting"
            ]
        }
    ]
}